IQVIA Holdings has recently seen its consensus analyst price target rise significantly, climbing from $223.42 to $246.84.

Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.

Two major themes cut across the week’s news: the profound integration of advanced technology, particularly Artificial ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

Oakmark spotlights six stocks driving AI, M&A, and analytics upside, while navigating debt, guidance cuts, and valuation ...

STAAR Surgical Company 25510 Commercentre Drive Lake Forest, CA 92630 Dear Members of the Board: I congratulate the Board on STAAR Surgical's strong results for the third quarter ended September 26, ...

On November 5, 2025, IQVIA Holdings Inc. announced the appointment of Dr. William G. Kaelin Jr. to its Board of Directors. Dr. Kaelin, a Nobel Prize-winning scientist with extensive expertise in ...

Ibnsina Pharma ranked first in non-pharma product distribution across pharmacies in Egypt during the first nine months of ...

Datavault AI believes this technology has the potential to extend into a Pharmaceutical Exchange platform, which could transform the pharmaceutical industry by enabling efficient, secure asset ...

Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing ...

ZTlido ® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba ® is the subject of an exclusive, transferable license to use the ...